Home - National Multiple Sclerosis Society

Skip to navigation Skip to content
National MS Society

Promising results from phase III trials of alemtuzumab, taken once-yearly by infusion, and oral BG-12 were reported in April at the annual American Academy of Neurology meeting.

Email not displaying correctly? View it in your browser.

Alemtuzumab and BG-12 backed by data

Promising results from phase III trials of alemtuzumab (Genzyme/Sanofi), taken once-yearly by infusion, and oral BG-12 (Biogen Idec) were reported in April at the annual American Academy of Neurology meeting in New Orleans. Genzyme says they’ll file soon for FDA approval of alemtuzumab; Biogen has already submitted BG-12 for FDA approval.

Read more news from AAN

 Find us on Facebook 

twitter youtube flickr linkedin googleplus MSConnection.org


May 30 is World MS Day. Connect to create awareness


Momentum on your laptop, phone or tablet.

eNews Teaser 2 Image 6-10Sign up now: Progressive MS, the Next Frontier webcast

On May 23, from 7:00-8:00 p.m. ET, join a panel of experts for a live nationwide webcast “The Next Frontier: Understanding and Treating Progressive MS.” Topics will include: Why there aren’t more treatments for progressive MS; what’s on the horizon for stopping or reversing progression; and things people can do to maximize their quality of life.

Register now


Double your giftEvery dollar gets doubled

Thanks to the generosity of Pure Protein, your gift will be doubled to help us get that much closer to a world free of MS by funding research and supporting programs and services that touch the lives of people with MS and their families.

Donate Now

More MS News 

May 11: Speeding clinical trials for people with progressive MS: Outcomes published from an international workshop on MS disability measurement tools

April 25: What triggers MS in kids? Pediatric network and other sites recruiting for study of environmental and genetic risk factors

Read more about these and other recent reports

This communication is partially sponsored through the generous support of
Biogen Idec; Novartis Pharmaceuticals Corporation; and Teva Neuroscience, Inc.

MS Active Source Novartis
Join a Walk MS Event       Join a Bike MS Event      Shop at the Society Store

National MS Society | View as Web page | Subscribe | Legal Notice/Privacy Policy | Email Preferences | Unsubscribe

MS stops people from moving. The National MS Society exists to make sure it doesn’t. We are a collective of passionate individuals, moving together to create a world free of MS.

Please do not reply to this email as we are unable to quickly respond to messages sent to this address. To receive information about living with MS, Bike MS or Walk MS — or to contact National MS Society staff in your area — please
visit our website.

Early and ongoing treatment with an FDA-approved therapy can make a difference for people with multiple sclerosis. Learn about your options by talking to your health care professional and contacting the National MS Society at http://www.nationalmssociety.org/ or 1-800-344-4867.

National Multiple Sclerosis Society | 733 Third Avenue | New York, NY | 10017

This message was sent to   .
To ensure that you continue to receive our emails, please add us to your address book.